Anti-Infective & Antimicrobial Agents
Formulations developed for the management of bacterial, fungal, and other microbial infections across diverse therapeutic needs. Includes antibacterial, antibiotic, antifungal, and other antimicrobial therapies designed to support effective infection management.
16
Products (SKUs)
Who-GMP
Certified Facility
FDCA
(Gujarat) Approved
Export
Ready
| SR | PRODUCT NAME | DOSAGE FORM | PHARMACOLOGICAL SUB-CLASS |
|---|---|---|---|
| 1 | Ciprofloxacin Tablets 500 mg | Tablet | Fluoroquinolone Antibiotic |
| 2 | Ciprofloxacin Tablets USP 500 mg | Tablet (USP) | Fluoroquinolone Antibiotic |
| 3 | Ciprofloxacin Hydrochloride & Ornidazole Tablets | Tablet (Combination) | Fluoroquinolone + Nitroimidazole |
| 4 | Levofloxacin 750 mg Tablet | Tablet | Fluoroquinolone Antibiotic |
| 5 | Doxycycline Capsules 100 mg | Capsule | Tetracycline Antibiotic |
| 6 | Metronidazole Tablets 500 mg | Tablet | Nitroimidazole (Antiprotozoal/Antibacterial) |
| 7 | Metronidazole Tablet USP 500 mg | Tablet (USP) | Nitroimidazole |
| 8 | Trimethoprim 80 mg + Sulfamethoxazole 400 mg Tablet USP | Tablet (USP) | Sulfonamide + DHFR Inhibitor (Co-trimoxazole) |
| 9 | Fluconazole Tablets 150 mg | Tablet | Azole Antifungal |
| 10 | Fluconazole Tablets BP 150 mg | Tablet (BP) | Azole Antifungal |
| 11 | Fluconazole Tablets USP 150 mg (×2 entries) | Tablet (USP) | Azole Antifungal |
| 12 | Ivermectin Tablets USP 3 mg | Tablet (USP) | Antiparasitic / Anthelmintic |
| 13 | Nitazoxanide 500 mg Tablet | Tablet | Antiprotozoal / Anthelmintic |
| 14 | Fosfomycin Tromethamine Oral Powder 3 gm | Oral Powder Sachet | Phosphonic Acid Antibiotic (UTI) |
| 15 | Fosfomycin Tromethamine Oral Powder 3 gm (Duplicate Entry) | Oral Powder Sachet | Phosphonic Acid Antibiotic (UTI) |
| 16 | Levocetirizine Dihydrochloride 10 mg Tablets | Tablet | 2nd-Gen Antihistamine (also Respiratory) |
PARTNER FOR BETTER HEALTH OUTCOMES
Let’s build healthier tomorrows together.
We are open to partnerships, tenders, and global collaborations.
Get in touch with our team to explore opportunities.
